missing translation for 'onlineSavingsMsg'
Learn More

GLPG0187, MedChemExpress

Product Code. p-200099981
Encompass_Preferred
Click to view available options
Quantity:
1 mg
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
1mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16493048

Brand: Medchem Express HY100506

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity; inhibits αvβ1-integrin with an IC50 of 1.3 nM.

GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity

Specifications

Chemical Name or Material GLPG0187
CAS 1320346-97-1
Color White
Purity Grade Notes Research
Molecular Formula C29H37N7O5S
Quantity 10 mg
Solubility Information DMSO : 12.5 mg/mL (20.98 mM; ultrasonic and warming and heat to 60°C) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
SMILES O=C(O)[C@H](CNC1=NC(C)=NC(N2CCC(C3=NC4=C(CCCN4)C=C3)CC2)=C1C)NS(=O)(C5=CC=C(OC)C=C5)=O
Molecular Weight (g/mol) 595.71
Formula Weight 595.71
Percent Purity 98.95%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.